Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0001274225-21-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-05 | 2021-08-03 | MYGN | LANGER DENNIS | Dir | S - Sale+OE | $34.75 | -30.0K | 89.5K | -25% | -$1.04M |
| D | 2021-08-05 | 2021-08-03 | MYGN | LANGER DENNIS | Dir | M - OptEx | $25.39 | +30.0K | 119.5K | +34% | +$761.7K |
| D | 2021-08-05 | 2021-08-03 | MYGN | LANGER DENNIS | Dir | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | S | D | 30,000 | $34.75 | 89,527 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-03 | M | A | 30,000 | $25.39 | 119,527 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-03 | M | D | 30,000 | $0.00 | 0 | D | $25.39 · — to 2021-12-05 | 30,000 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |